Comparative study of sodium nitroprusside induced vasodilation of human placental veins from premature and full-term normotensive and preeclamptic pregnancy.

The objective of this study was to determine whether nitrovasodilator (nitric oxide donor) drug induced relaxation is different between preeclamptic and normotensive pregnancy. Human placental veins were collected at the time of delivery from normotensive (n = 6 premature, n = 6 full term) and preeclamptic (n = 6 premature, n = 3 full term) women and cut into rings. Cumulative concentration-response curves were performed on 5-hydroxytryptamine-contracted rings for the nitrovasodilator agent, sodium nitroprusside (SNP). The EC50 values were determined from the SNP concentration-response curves of the individual subjects, and were compared across gestational age and between preeclamptic and normotensive pregnancy by two-way ANOVA. There was no difference in the SNP EC50 values for normotensive and preeclamptic human placental veins in either the premature or full-term study groups. However, for both normotensive and preeclamptic pregnancy, the SNP EC50 value for full-term placental vein was greater than that for premature tissue. The sensitivity of human placental veins to SNP is similar between preeclamptic and normotensive pregnancy at similar gestational ages, but is increased in premature compared with full-term pregnancy in both preeclamptic and normotensive pregnant women.

[1]  L. Poston,et al.  Abnormal endothelial cell function of resistance arteries from women with preeclampsia. , 1993, American journal of obstetrics and gynecology.

[2]  T. Khong,et al.  An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy--evidence that endothelium is focally disrupted by trophoblast in preeclampsia. , 1992, American journal of obstetrics and gynecology.

[3]  J. Brien,et al.  Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation. , 1991, Canadian journal of physiology and pharmacology.

[4]  J. Roberts,et al.  Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. , 1990, The Journal of clinical endocrinology and metabolism.

[5]  D. Harrison,et al.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide , 1990, Nature.

[6]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[7]  J. Brien,et al.  A comparative study of glyceryl trinitrate biotransformation and glyceryl trinitrate induced relaxation in bovine pulmonary artery and vein. , 1987, Canadian journal of physiology and pharmacology.

[8]  J. Brien,et al.  Endothelium-dependent relaxation of rabbit aorta by acetylcholine requires ethylenediaminetetraacetic acid. , 1986, Canadian journal of physiology and pharmacology.

[9]  H. Danielsen,et al.  Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. , 1985, Clinical science.

[10]  H. Sinzinger,et al.  Morphological changes in the umbilical arteries of babies born to pre-eclamptic mothers: an ultrastructural study. , 1984, Placenta.

[11]  C. Reich,et al.  Effects of vasoactive agents on isolated human umbilical arteries and veins. , 1972, The American journal of physiology.